Navigation Links
Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
Date:10/4/2007

), has been shown to reduce pain after only a single administration for weeks to months in multiple settings in numerous mid-stage clinical trials for site-specific, moderate-to-severe pain. Anesiva is based in South San Francisco, CA. For more information about Anesiva's leadership in the development of products for pain management, and an overview of the clinical challenges being addressed by its product candidates, go to http://www.anesiva.com.

Forward Looking Statements

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. Forward- looking statements in this press release include matters that involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. Such risk factors include, among others: the timing and results of our clinical trials, whether Adlea will provide pain relief for weeks to months, whether Anesiva is able to manufacture our products on commercially reasonable terms, whether Anesiva can commercially release new products successfully and the degree to which these products gain market acceptance. Actual results may differ materially from those contained in the forward-looking statements in this press release.

Additional information concerning these and other risk factors is contained in Anesiva's quarterly report on Form 10-Q for the quarter ended June 30, 2007.

Anesiva undertakes no obligation and does not intend to update these forwar
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Malvern initiates European user group meetings for chemical imaging
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... June 1, 2015 NSHOA Cancer Center ... today announced positive, top-line results from its recently ... efficacy and safety of the Company,s 5-HT 3 ... (granisetron injection, extended release) as part of a ... 1 ) receptor antagonist fosaprepitant and the IV ...
(Date:6/1/2015)... , June 1, 2015 Researchers from ... Case Western Reserve University School of Medicine will present ... a potential novel combination treatment for cancer patients with ... mutations in small cell lung cancer (SCLC), at the ... Annual Meeting in Chicago . ...
(Date:6/1/2015)... 1, 2015   OTC Markets Group Inc. ... Connected financial marketplaces for 10,000 U.S. and global ... San Diego -based biopharmaceutical company, on its ... only public venture market for entrepreneurial and development ... "We,re happy to congratulate ...
Breaking Medicine Technology:New cancer therapy study results - MAGIC Trial 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 3OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
(Date:6/1/2015)... June 02, 2015 The National ... F. Cornett, DSL, LSSBB (C), First Sergeant A Co., ... Woman of the Year Circle. She is recognized with ... is the nation's leading networking organization exclusively for professional ... operating Local Chapters. , “I'm pleased to recognize Sergeant ...
(Date:6/1/2015)... 01, 2015 Carson Energy also announced ... investors IRA transactions. AdvantaIRA Trust, LLC is the country’s ... ability to fund positions using IRA’s does 2 things:, ... a project, even if there current cash position will ... funding source for Carson and their investors to be ...
(Date:6/1/2015)... The federal court overseeing hundreds of ... Case Management Order governing case selection for bellwether trials ... Order which was issued in the U.S. District Court, ... the parties to submit a Proposed Case Management Order ... parameters and the process for selecting AbbVie-only plaintiffs in ...
(Date:6/1/2015)... Atagi Plastic Surgery and Skin Aesthetics is ... Ultherapy® Ultra Treatment Provider by Ulthera, the manufacturer ... one of only six practices in Colorado to be ... , Atagi Plastic Surgery and Skin Aesthetics’ experience and ... the practice to earn the distinction of being named ...
(Date:6/1/2015)... Linda Kincaid, age 67, knew something was ... At first she thought it was just a part of ... more than that. After going to the doctor, she received ... afraid about what might happen to her. , Linda is ... with valve disease each year. Valve disease involves damage to ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3
... New York, NY Two non-profit organizations committed ... have joined together to address the critical shortage ... Conference Foundation, dedicated to curing pediatric cancers, has ... Research Foundation, the leading charity supporting innovative young ...
... , THURSDAY, Jan. 5 (HealthDay News) -- Giving antibiotics to ... infection rates in newborns, according to a new study. ... in high-income nations and should also be used in developing ... author Dr. Karen Edmond, of the London School of Hygiene ...
... clinical trial found that rilonacept, an inhibitor of ... flares that occur when initiating uric acid-lowering therapy. ... IL-1 targeted therapy in prevention of gout flaresshow ... serious infections or treatment-related serious adverse events reported. ...
... women against infection from one of the two types of herpes ... New England Journal of Medicine . The vaccine was ... did not protect women from herpes simplex virus type 2 (HSV-2). ... herpes caused by HSV-1 58 percent fewer -- in women ...
... WEDNESDAY, Jan. 4 (HealthDay News) -- New research shows ... for also suffering from depression and so-called "disordered eating," ... "We found that most [study] participants frequently adhered ... diet was related to increased vitality, lower stress, decreased ...
... 2012 Abraham Kovoor was studying a brain protein, called ... random and repetitive body movements that are side effects of ... studying these side effects, which are called dyskinesia, Kovoor, an ... Pharmacy, discovered that RGS9 2 also plays a role in ...
Cached Medicine News:Health News:Damon Runyon, Sohn Foundation partner to address funding shortage in pediatric cancer research 2Health News:Antibiotics in Pregnancy May Shield Newborns From Strep B 2Health News:Clinical trial demonstrates that rilonacept significantly reduces gout flares 2Health News:Clinical trial demonstrates that rilonacept significantly reduces gout flares 3Health News:Research shows progress toward a genital herpes vaccine 2Health News:Research shows progress toward a genital herpes vaccine 3Health News:Celiac Disease in Women Linked to Depression Risk 2Health News:URI pharmacy researcher discovers new gene that regulates body weight 2Health News:URI pharmacy researcher discovers new gene that regulates body weight 3
... of the Criterion precast gel system, allows you ... a single run. Criterion gels are wider and ... mini gel. They accommodate Bio-Rad's 11 cm ReadyStrip ... of separation and speed in 2-D electrophoretic applications. ...
... Mini-Vertical Gel System simplifies the process of separating ... It is able to run four gels at ... maximize utility and throughput, the 120 mini-vertical runs ... (W x L) at one time. The 120 ...
... High-Throughput (HTP) Protein Electrophoresis ... integrated pre-cast gel system ... protein analysis. It consists ... E-Base™ integrated power device, ...
... agarose gel electrophoresis into an automated, high-throughput ... bufferless, pre-cast system is ideal for analyzing ... and more. Fully automated, robot-compatible, and ready ... system makes your high-throughput screening assignments as ...
Medicine Products: